These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 6972690)

  • 1. Drug effects on autoantibodies and immune complexes.
    Holborow EJ
    Agents Actions Suppl; 1980; 7():58-61. PubMed ID: 6972690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactions between rheumatoid factors and antinuclear autoantibodies: their occurrence in a concealed state in rheumatoid disease (arthritis); effect of D-penicillamine].
    Mach PS; Delbarre F; Piatier D
    C R Seances Acad Sci D; 1980 Feb; 290(8):575-8. PubMed ID: 6767559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunopathologic mechanism in some ocular diseases].
    Rogoz S; Avramescu C; Siloşi I; Drackoulogona O; Badea P; State A
    Oftalmologia; 2002; 54(3):51-5. PubMed ID: 12723199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles antibodies and autoantibodies in autoimmune disorders.
    Triger DR; Gamlen TR; Paraskevas E; Lloyd RS; Wright R
    Clin Exp Immunol; 1976 Jun; 24(3):407-14. PubMed ID: 1084820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Wager O
    Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D-penicillamine on circulating protein complexes in rheumatoid arthritis and primary biliary cirrhosis.
    Wollheim FA
    J Rheumatol Suppl; 1981; 7():74-9. PubMed ID: 7014877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of D-penicillamine on inflammatory and immune reactions.
    Harth M; Keown PA; Orange JF
    Clin Invest Med; 1984; 7(1):45-51. PubMed ID: 6723124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between IgM antiglobulins and IgG antinuclear antibodies. Some aspects of D-penicillamine activities.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1979 May; 36(2):311-6. PubMed ID: 383333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune complex and rheumatoid arthritis].
    Kasukawa R
    Ryumachi; 1994 Apr; 34(2):175-6. PubMed ID: 8202835
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immune complexes in the pathogenesis of rheumatoid arthritis].
    Lavrova TR
    Ter Arkh; 1978; 50(10):125-31. PubMed ID: 81534
    [No Abstract]   [Full Text] [Related]  

  • 13. [Are antinuclear factors a contraindication for penicillamine treatment in patients with rheumatoid arthritis? (author's transl)].
    Scherak O; Hiesberger H; Kolarz G
    Wien Klin Wochenschr; 1978 Feb; 90(3):95-6. PubMed ID: 304637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
    Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
    J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
    Traycoff RB; Rogers WW; Gregory SA
    J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune phenomena in D-penicillamine therapy].
    Kolarz G; Ludwig H; Sabeti M; Scherak O
    Acta Med Austriaca; 1975; 2(4):130-3. PubMed ID: 1083615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biopathology of disseminated lupus erythematosus].
    Youinou P; Amoura Z
    Rev Prat; 1998 Mar; 48(6):603-8. PubMed ID: 9781129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinuclear antibodies.
    Peltier AP; Estes D
    Pathobiol Annu; 1972; 2():77-109. PubMed ID: 4129769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.